San Marino, 31 January 2025 – Last year was, without a doubt, a very successful one. Despite the global economic crisis conditioned by numerous conflicts scattered around the globe, LSM-Med is pleased to have saluted 2024 as another step of growth for the company, with positive revenue increases in many respects.
Moving right into the heart of the turnover itself, the first noteworthy fact concerns the comparison of total revenues in 2024 and 2023. Over the past year, LSM-Med has topped 7.62 million euros, a number that corresponds to an increase of 8.4 % over the previous year.
Another remarkable increase that occurred during the same time frame involves the sales of catalogue products, which grew by 6 per cent over 2023. This excellent percentage owes much of its success to the SuperNail GT, a product that wears the crown of absolute leader in the overall offering. We are talking about a femoral nail that embodies the company’s decades-long history, an implant that continues uninterruptedly to enjoy high approval ratings throughout the surgical world. Not surprisingly, it can individually boast 24 % of the company’s total catalogue product sales.
In purely percentage terms, on the other hand, the largest improvement is in foreign market turnover, indicative of LSM-Med’s growing internationalisation. In this particular category, the increase that has occurred is as much as 45 % over 2023.
As a matter of fact, the company has achieved substantial increases in sales in certain countries, first and foremost Bosnia and Brazil. The surprises, however, do not end there, as new economic relations have also been established in the following states:
- Mexico
- Venezuela
In conclusion, as a testament to the excellent health of the company, it is worth looking at the overall performance over the past four years. During this time, LSM-Med has totalled a positive turnover variation of 38 percent, a number that outlines excellent prospects for both 2025 and the more distant future.
